{
    "Trade/Device Name(s)": [
        "ARCHITECT\u00ae HAVAB\u00ae-M",
        "ARCHITECT\u00ae HAVAB M Calibrator",
        "ARCHITECT\u00ae HAVAB\u00ae-M Controls"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostic Division",
    "510(k) Number": "K063329",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL"
    ],
    "Summary Letter Date": "March 22, 2007",
    "Summary Letter Received Date": "March 23, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3310"
    ],
    "Regulation Name(s)": [
        "Hepatitis A virus (HAV) serological assays"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology",
        "serology"
    ],
    "Analyte(s)": [
        "IgM antibody to hepatitis A virus (IgM anti-HAV)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Neonatal serum"
    ],
    "Specimen Container(s)": [
        "Dipotassium EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System",
        "ARCHITECT i 2000",
        "ARCHITECT i 2000SR"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott ARCHITECT HAVAB-M CMIA for qualitative detection of IgM antibody to hepatitis A virus in serum and plasma.",
    "Indications for Use Summary": "Qualitative detection of IgM antibody to hepatitis A virus in adult, pediatric, and neonatal serum and plasma to aid in diagnosis of acute or recent hepatitis A infection, not intended for blood donor screening.",
    "fda_folder": "Microbiology"
}